We find, using three CAC models (infection with Helicobacter or E. coli/ETBF, or DSS treatment), that antioxidants or iNOS inhibitors reduce tumorigenesis and 8-oxoG levels in the colon without affecting other facets of inflammation, effectively separating these two phenomena. Here, NOS2 is linked to infection.